ContributorsPublishersAdvertisers

Boosting T cells improves survival in mice with glioblastoma

Newswise
 2022-01-15

Cover picture for the articleNewswise — Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis. But a new study from researchers...

www.newswise.com

Comments / 0

Comments / 0